Crossref
ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?
ASRA News · 01.05.2026 · 51 (2)
DOI: 10.52211/asra050126.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASRA News, online erschienen am 01.05.2026. Verfasst von D. Hao und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hao, D., Narang, S., & Eshraghi, Y. (2026). ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?. ASRA News, 51(2). https://doi.org/10.52211/asra050126.005
Vancouver
Hao D, Narang S, Eshraghi Y. ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?. ASRA News. 2026;51(2). doi:10.52211/asra050126.005
BibTeX
@article{Hao2026,
author = {Hao, D. and Narang, S. and Eshraghi, Y},
title = {ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?},
journal = {ASRA News},
year = {2026},
volume = {51},
number = {2},
doi = {10.52211/asra050126.005}
}
EUVIMED